Feigin Discusses the Association Between Benzodiazepines and Pancreatic Cancer Outcomes

Season 9 Episode 41  ·  Nov 13, 2023, 07:30 PM

Headliner
Share
Subscribe

Dr Feigin discusses findings from a study on the varying effects of the benzodiazepines lorazepam and alprazolam on PFS outcomes for patients with pancreatic cancer.

Share
Subscribe
Next
Halmos Highlights Evaluation of the EGFR Inhibitor BDTX-1535 in NSCLC
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air